{"entity":{"id":"paper-mirzaev-tashkent-cervical-registry-2014-2024-jncics-2026","kind":"paper","name":"Cervical cancer trends in Tashkent, 2014 to 2024, from the city oncology register","aka":[],"tldr":"In Tashkent's cancer register, 2,140 women had cervical cancer or carcinoma in situ in 2014 to 2024. After screening projects began, in situ diagnoses rose and advanced-stage disease fell, but three quarters of staged invasive cancers were still stage II to IV.","summary":"Published as \"Population-based registry analysis of cervical cancer trends in Tashkent, Uzbekistan 2014-2024\". The authors analysed Tashkent City Oncoregister data for women diagnosed with invasive cervical cancer or carcinoma in situ, calculating age-standardised incidence and mortality and survival, to look at the effect of a Korea Foundation for International Healthcare (KOFIH) screening project and UNFPA and UNDP HPV testing initiatives.","asOf":"2026-11-11","links":[{"label":"JNCI Cancer Spectr 2026","url":"https://doi.org/10.1093/jncics/pkag107"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/42853092/"}],"tags":[],"related":[],"cancers":["cervical"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["uzbekistan-cancer-registry"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"journal":"JNCI Cancer Spectrum","year":2026,"doi":"10.1093/jncics/pkag107","pmid":"42853092","authors":"Mirzaev UK, Juraev JR, Sharipova IP, et al.","paperType":"observational","findings":["The age-standardised incidence of invasive cervical cancer was 14.9 per 100,000.","After the screening projects began, carcinoma in situ diagnoses rose 3.4-fold and the share of stage III to IV disease fell by 43%.","Five-year survival ranged from 91.5% for carcinoma in situ to 27.8% for stage IV; crude mortality fell from 10.2 to 1.1 per 100,000 between 2014 and 2024.","76.6% of staged invasive cases were stage II to IV, and more than 80% of women had never been screened."],"whatItMeans":"One of the few published analyses of an Uzbek population register, it shows organised screening finding cervical cancer earlier in the capital, and how far coverage still has to go.","caveats":["One city.","Before and after comparison, not a trial; other changes over the period may contribute."],"participants":2140},"route":"/key-papers/paper-mirzaev-tashkent-cervical-registry-2014-2024-jncics-2026/","neighbours":{"cancer":[{"id":"cervical","kind":"cancer","name":"Cervical cancer","route":"/cancers/cervical/"}],"institution":[{"id":"uzbekistan-cancer-registry","kind":"institution","name":"Uzbekistan national cancer registry (Cancer-registr)","route":"/institutions/uzbekistan-cancer-registry/"}]}}